Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient

Michael S Stalvey1,2, Viktoria Havasi1,2, Katherine L Tuggle2,3

  • 1Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, United States of America.

Plos One
|December 1, 2017
PubMed

Insights

Young cystic fibrosis (CF) rats lacking functional CFTR show impaired growth and bone development. Reduced growth plate size and lower IGF-I levels suggest CFTR is crucial for normal bone growth, independent of lung or pancreatic issues.

Area of Science:

  • Bone Biology
  • Genetics
  • Pediatrics

Background:

  • Reduced growth and osteopenia are common in cystic fibrosis (CF).
  • The mechanisms underlying growth reduction in CF are not fully understood.
  • Improved weight and height correlate with better lung function and overall health in CF patients.

Purpose of the Study:

  • To investigate growth in young CF rats using a novel CFTR knockout rat model.
  • To evaluate femur length, bone microarchitecture, growth plate characteristics, and serum IGF-I concentrations in CF animals.

Main Methods:

  • Measurement of femur length as a growth surrogate in wild-type (WT) and Cftr-/- rats.
  • Micro-computed tomography (micro-CT) for quantitative bone analysis.
  • Bone histomorphometry, growth plate analysis, and serum IGF-I concentration comparison.

Main Results:

  • Cftr-/- rats exhibited reduced femur length in both males and females compared to WT.
  • Bone microarchitecture (trabecular and cortical) was adversely affected in Cftr-/- rats.
  • Growth plate thickness, hypertrophic zone thickness, and mean hypertrophic cell volume were reduced, alongside severely decreased serum IGF-I concentrations.

Conclusions:

  • Young Cftr-/- rats displayed reduced growth and bone content even without overt lung or pancreatic disease.
  • Decreased growth plate size and lower IGF-I concentrations indicate the mechanistic basis for the observed growth phenotype.
  • These findings highlight the intrinsic role of CFTR in maintaining normal bone growth, independent of other clinical factors.
Abstract